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The generation of eﬃcient candidate vaccines against bovine tuberculosis will contribute to the control of this zoonotic disease.
Rationally attenuated Mycobacterium bovis strains generated by knockout of virulence genes are promising candidate vaccines.
However, to be eﬀective, these candidate vaccines should at least maintain the immunological properties of their virulent parental
M. bovis strains. Therefore, the aim of this study was to obtain an M. bovis strain deleted in the mce2 genes and evaluate the eﬀect
of the mutation on the immunological proﬁle elicited by the bacteria in cattle. We showed that the activation of CD4+ T cells in
cattle inoculated with the mutant strain was equivalent to that in animals inoculated with the parental strain. Moreover, after in
vitro stimulation, peripheral blood mononuclear cells from animals inoculated with the mutant produced higher levels of mRNA
Th-1 cytokines than the parental strain. Therefore, these results indicate that the mce2 mutant is a promising candidate vaccine
against bovine tuberculosis.
1.Introduction
Bovine tuberculosis (bTB) is not only serious animal and
zoonotic disease that causes signiﬁcant ﬁnancial loss but also
a public health hazard. While the main host of Mycobac-
terium bovis, the causative agent of bTB, is cattle, other
animals,includinghumans,mayalsobeaﬀected.Infectionin
humans occurs when unpasteurized milk (or derivatives) is
consumed or when people are in contact with infected cattle.
bTB is a factor that undermines the development of the dairy
and meat industry and international commerce. Therefore,
it is essential to control and eradicate this disease and an
eﬃcient vaccination strategy would help in the control of
bovine tuberculosis. Vaccination of cattle to control bTB is
particularly demanding in high-prevalence zones where it is
economically unfeasible to slaughter animals.
Rationallyattenuated,livereplicatingmutantsofM.bovis
are potential vaccine candidates. The advantage of using
attenuated M. bovis strains is that they produce a large
number of protective antigens, including those absent from
BCG [1]. Thus, vaccination with live attenuated M. bovis
can induce a stronger and persistent immune stimulation,
conferring higher levels of protection against tuberculosis
than BCG.
The M. bovis genome contains three operons designated
mce (mammalian cell entry). These operons, which encode
membrane and exported proteins, are highly conserved
in pathogenic and nonpathogenic mycobacteria [2]. In a
previous study, we have demonstrated that the mce2 operon
is essential for the survival of Mycobacterium tuberculosis,
the causative agent of human tuberculosis, during infection
in mice [3]. In that study, we found that M. tuberculosis2 Journal of Biomedicine and Biotechnology
knockout in the mce2 operon replicated less than its parental
strain in mouse organs after intratracheal inoculation of
animals. Our ﬁndings were consistent with previous obser-
vations supporting the involvement of mce operons in the
host-pathogen interaction [2, 4–9]. In particular, in a recent
study Marjanovic et al. [10] demonstrated that mice infected
with an M. tuberculosis mutant in the mce2 operon survive
longer than those infected with its parental and virulent
strain, although the replication of both strains in organs was
equivalent. The use of the M. tuberculosis Δmce2 strain as a
vaccine confers better protection than BCG in both mice and
guinea pigs challenged with a hypervirulent M. tuberculosis
strain [11, 12]. M. bovis is closely related to M. tuberculosis,
and both species are included in the M. tuberculosis complex.
In addition, as both organisms can cause identical clinical
disease in humans and are genetically extremely similar, it
is likely that many of the virulence factors of M. bovis are the
same as those of M. tuberculosis [13]. Based on these facts,
we propose an M. bovis knockout strain in the mce2 operon
as a candidate vaccine against bTB. In order to determine
the immunogenic properties of this candidate, in this study
we characterized the immunological proﬁle elicited in cattle
by the M. bovis mce2 mutant strain towards M. bovis
antigens and compared it with that elicited by its parental
and virulent strain NCTC 10772 [14]. To this end, we
measuredthecytokinemRNAexpressioninperipheralblood
mononuclearcells(PBMCs)anddeterminedthelymphocyte
subsets involved in recalling activation of PBMCs from cattle
inoculated with the candidate vaccine in response to M.
bovis antigens. We found that inoculation of cattle with the
candidate vaccine stimulates both CD4+ and CD8+ T-cell
responses to produce Th1-associated cytokines.
2. Results
2.1. Construction of mce2 Mutant of M. bovis. By using
the gene knock-out system described by Parish and Stoker
[15], we created a mutant strain of M. bovis carrying a
unmarked-chromosomal deletion of the region spanning
the mce2A-mce2B genes (Figure 1(a)). The deletion was
conﬁrmed by PCR using primers that hybridize outside the
deleted region. As shown in Figure 1(b), an amplicon of
1,831bp corresponding to the mce2A and mce2B genes and
adjacent regions was obtained in the wild type strain, while
in the mutant, the ampliﬁed DNA fragment was of 177bp
and corresponded to the Δmce2A-mce2B locus. Primers that
hybridize in sigA ampliﬁed the expected fragment in both
strains, indicating the integrity of the DNA samples used
in the PCR reactions. The mutant strain was designated
MbΔmce2.
2.2. Activation of CD4+, and CD8+ in PPDB-Stimulated
PBMCs from Cattle Inoculated with the Candidate Vaccine
Δmce2. To evaluate the recall response to puriﬁed protein
derivative (PPDB) of lymphocyte subsets in animals inoc-
ulated with either the candidate MbΔmce2 or its wild type
parental strain (NCTC 10772), we used a ﬂow cytometry-
based proliferation assay. In PBMCs isolated 15 and 90
days after infection (dpi), activation of CD4+ and CD8+
signiﬁcantly increased upon stimulation with PPDB (Figures
2(a) and 2(b)). After speciﬁc stimulation, the expression of
IL-2R in CD4+ cells, which indicates lymphocyte activation,
increased along the time of infection (P<0.01) with similar
rates in both groups (Figure 3(a)). The expression of IL-
2R in CD8+ cells also showed the same trend, but it was
only signiﬁcant in animals inoculated with the wild type
strain (P<0.05) (Figure 3(b)). Importantly, in PBMCs
from animals before the infection, the percentages of CD4+
and CD8+ cells were not signiﬁcantly altered upon PPDB
stimulation, indicating that the animals used in this study
were neither previously sensitized nor infected with M. bovis.
2.3. Expression of Cytokines in PBMCs from Cattle Inoculated
with the Candidate Vaccine MbΔmce2. In order to evaluate
Th1 and Th2 immune responses in cattle inoculated with the
candidate vaccine strain MbΔmce2, we assessed the cytokine
expression proﬁle in PBMCs by measuring cytokine mRNAs
after stimulating the cells with PPDB (Figure 4). Values
for sequential samples were normalized to values before
inoculation for each animal.
PBMCs obtained from cattle inoculated with MbΔmce2
at 15dpi responded to PPDB stimulation by expressing 16.2-
fold more IFN-γ mRNA than cells from animals before
inoculation. In contrast, a lower level of IFN-γ was detected
in animals inoculated with the wild type strain (P<0.05).
However, at 90dpi, the expression of IFN-γ increased in
cattle inoculated with the wild type, while it showed only
a slight reduction in those inoculated with the mutant.
The expression of interleukin-2 (IL-2) in PBMCs from
both animal groups was signiﬁcantly diﬀerent from that
in PBMCs from animals before the inoculation. However,
the expression level of this cytokine was equivalent in both
groups and maintained during the time points assayed. Only
the group inoculated with the mutant responded to PPDB
stimulation with production of IL-12 and TNF-α (P<
0.0001).
IL-10 and IL-4 gene expression was evaluated to assess
Th2 responses. Stimulation with PPDB induced greater IL-
10 gene expression in animals inoculated with the mutant
than in those inoculated with the wild type strain at both
time points assayed (P<0.005). At 15dpi, the expression of
IL-4 was similar in both groups, while at 90dpi, the level of
IL-4 was higher in the animals inoculated with the wild type
strain (P<0.005).
3. Discussion
The eﬃcacy of BCG to protect against tuberculosis in
humans has shown to be highly variable and depending on
uncertain factors of the populations tested. Field evaluation
of the protective eﬃcacy of BCG against bovine tuberculosis
has indicated that BCG is not capable of protecting 100% of
the animals [16, 17]. One possible explanation of this failure
is that exposure to environmental mycobacteria compro-
mises the protection eﬃcacy of BCG in cattle, as it happens
with the use of BCG in humans [18]. To overcome the
incomplete protection aﬀorded by BCG, numerous vaccineJournal of Biomedicine and Biotechnology 3
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Figure 1: Construction of the M. bovis Δmce2 mutant strain. (a) An unmarked mutant strain of M. bovis carrying a chromosomal deletion
of the region spanning the mce2A-mce2B genes was created by the gene knock-out system described by Parish and Stoker [15]. The mutant
strain was designated MbΔmce2. (b) PCR analysis of MbΔmce2 and the wild type strains. PCRs were performed by using primers that
hybridize outside the mce2A-mce2B region (lanes 3 and 5) or in sigA (lanes 2 and 4). Chromosomal DNA from the parental strain (lanes 2
and 3) or from the mutant strain (lanes 4 and 5) was used as template in the PCR reactions. Lane 1 is the molecular weight marker (1Kb
ladder Promega).
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Figure 2: Percentages of lymphocyte cell subsets CD4+ (a) and CD8+ (b) expressing CD25 of PBMCs from animals inoculated with either
MbΔmce2 (n = 4, triangle) or NCTC 10772 (n = 3, circle) stimulated with PPDB (black) or PBS (white) at diﬀerent time points. Data
were analyzed using the Wilcoxon matched pair test for cells with and without PPDB stimulation (∗statistically signiﬁcant P<0.05 and
∗∗statistically signiﬁcant P<0.01). The means ± SEM are indicated.
strategies have been developed and tested in experimental
vaccineassays.Amongthem,prime-booststrategiescombin-
ing single antigens and BCG have been shown to improve
the protective eﬃcacy of BCG signiﬁcantly. Inspections on
the genomic sequences of M. bovis isolates and BCG strains
have revealed that at least 16 regions of diﬀerences (RDs)
are absent from the BCG chromosomes [19, 20]. Many
of these RDs encode for powerful and protective antigens
[1, 21]. Thus, an attractive alternative to the use of BCG
as a veterinary vaccine is the development of attenuated4 Journal of Biomedicine and Biotechnology
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Figure 3: Percentages of the activated lymphocyte cell subsets CD4+ (a) or CD8+ (b) of PBMCs stimulated with PPDB from animals
inoculated with MbΔmce2 (white square) or NCTC 10772 (black triangle). The means ± SEM are indicated. ∗statistically signiﬁcant P<
0.05.
M. bovis strains deleted in proteins that are nonantigenic but
relevant for virulence. Here, we describe the construction of
amutantstrainofM.bovis anditsimmunological evaluation
as a candidate attenuated live vaccine against bTB. Based on
previous ﬁndings indicating that inactivation or deletion of
the mce2 operon attenuates M. tuberculosis [3], we obtained
anattenuated nonreverting M. bovis strain by deletion of two
mce2 genes. Importantly, since the experimental approach
used to generate this mutant strain avoids the insertion of
any selective and nonselective gene marker into the bacterial
chromosome, we created this mutant in compliance with the
criteria of tuberculosis vaccine development [22]. Another
important aspect of this candidate vaccine strategy is that the
absence of Mce2A and Mce2B proteins in the mutant strain
could be used as marker to diﬀerentiate infected animals
from vaccinated ones.
Giventhatthereisnodoubtabouttheessentialprotective
role of CD4+ T cells to control tuberculosis infections, it is a
conditionthatanycandidatevaccineiscapableofstimulating
thiscellpopulation.Therefore,themosteﬀectivevaccination
strategies will be those that stimulate CD4+ T-cell responses
to produce Th1-associated cytokines. In accordance with
these requirements, the candidate vaccine Δmce2 elicited
strong T-cell responses in cattle, with activation of CD4+
following stimulation with the M. bovis-speciﬁc antigen
PPDB.
It has been demonstrated that CD8+ T cells are also
required for immunity against tuberculosis in a variety
of animal models as well as in humans [9, 23–27]. In
this regard, in the group of animals inoculated with the
mutant strain, the activation of CD8+ T cells was sustained
along the time of infection and increased at the last point
assayed, but this increase was not statistically signiﬁcant,
likely due to the reduced number of animals included
in the experiment. Similarly, subcutaneous inoculation of
cattle with Δmce2 induced activation of CD4+ and CD8+
following speciﬁc stimulation, but only the CD4+ T cells
responded at signiﬁcant levels (unpublished results).
Moreover, inoculation of the mutant strain in cattle
induced the production of Th1 expression of IL-12 responses
with production of IL-2, IL-12, TNF-α,a n dI F N - γ.S u r -
prisingly, the level of and TNF-α was higher in stimulated
PBMCs from animals inoculated with the mutant than in
those from animals inoculated with the wild type strain.
Thesedataindicatethat,incattle,MbΔmce2inducesastrong
Th1 response that is maintained for at least 90 days. These
observations are in contrast to that found by Marjanovic
et al., who have shown that an M. tuberculosis mutant in the
mce2 operon induces smaller amounts of proinﬂammatory
cytokines (TNF-α, IL-6, and MCP-1) in RAW cells than the
wild type H37Rv strain. However, considerable diﬀerences
between the systems used in both studies could explain
these disparities. In particular, these authors used an in vitro
murine model to determine the cytokines produced after
cell infection, while here we measured cytokines produced
after antigen stimulation of total bovine PBMCs. Although
it is still unclear why the mutant strain elicited stronger
proinﬂammatory response than the wild type strain, we
speculate that the lack of Mce2 lipid transporter could alter
the M. bovis cell wall composition, which, in turn, could
aﬀect the host’s immune response elicited by the bacteria.
Production of the anti-inﬂammatory cytokine IL-10 was
early detected in animals inoculated with the mutant strain.
In contrast, animals inoculated with the wild type strain
showed low IL-10 expression at 15 and 90dpi. At 15dpi,
IL-4 expression levels were similar in both groups, whereas
at 90dpi, the expression of this cytokine decreased in the
wild type group. Together, these results suggest that anti-
inﬂammatory responses in animals inoculated with the
mutant strain were generated to attenuate the adverse eﬀect
of an exacerbated inﬂammation in the host’s tissues driven
by the highly expressed IFN-γ.
The importance of the induction of multifunctional
CD4+ T cells producing diﬀerent cytokines simultaneously
for protection against tuberculosis has been previously
addressed in a mouse model [28]. Therefore, it will be of
interest to carry out further studies to establish whetherJournal of Biomedicine and Biotechnology 5
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Figure 4: Relative cytokine gene expression. Gene expression was measured in PBMCs from animals infected with either MbΔmce2 (n = 4,
white bars) or NCTC 10772 (n = 3, gray bars) stimulated with PPDB at 15 and 90dpi. Relative gene expression was calculated using
the 2-ΔΔCt method with E correction, using pol II and gadph mRNA expression as reference genes and the preimmune condition as the
calibrator. Data were analyzed using a two-tailed unpaired t-test (∗∗P<0.01, ∗∗∗P<0.001). The bars indicate the average ratios of infected
animals/uninfected animals ± SEM.
multifunctional CD4+ T cells are induced in MbΔmce2-
vaccinated cattle.
Given that the immune responses between bovines and
humans have been considered a determinant issue in the
development of diagnostic tools and vaccines for both
human and bovine tuberculosis [29], the results presented
here make this mutant an attractive candidate vaccine to be
tested against both bovine and human tuberculosis.
4. Conclusions
Here, we demonstrated that the lack of mce2 gene expres-
sion maintains the immunogenicity properties of M. bovis,6 Journal of Biomedicine and Biotechnology
favoring its ability to protect against bovine tuberculo-
sis. Although the results presented here make Δmce2 an
attractivecandidatevaccine,furtherstudiesaddressingsafety
and innocuity concerns are necessary before testing this
candidate in challenge assays.
5.MaterialandMethods
5.1. Bacterial Strains and Culture Media. All cloning steps
were performed in Escherichia coli Top10 (F-mcrAΔ(mrr-
hsdRMS-mcrBC) ϕ80lacZΔM15 ΔlacX74 nupG recA1
araD139 Δ(ara-leu)7697 galE15 galK16 rpsL(StrR) endA1
λ-). E. coli were grown either in Luria-Bertani (LB) broth
or on LB agar. When necessary, 50μg/mL kanamycin was
added to the LB media. M. bovis strains were grown in
Middlebrook 7H9 medium supplemented with 0.05%
Tween 80 or Middlebrook 7H10. Middlebrook media were
supplemented with albumin 0.5%, dextrose 0.4%, and 0.4%
pyruvate (ADP). To grow the knock-out M. bovis strain,
Middlebrook 7H10-ADP was supplemented with either
20μg/mL kanamycin plus 50μg/mL X-Gal or 2% sucrose.
5.2. General DNA Methodology. PCR ampliﬁcations from
genomic DNA templates were performed as previously
described [30]. Each primer contained base mismatches that
introduced a restriction site suitable for directional cloning.
Chromosomal DNA samples were obtained as described
by [31]. Puriﬁcation of plasmids and DNA fragments was
performed using the GFX Micro Plasmid Prep Kit (GE
Healthcare) and DNA and Gel Band Puriﬁcation Kit (GE
Healthcare), respectively, according to the manufacturer’s
instructions.
5.3. Construction of the M. bovis Δmce2 Mutant Strain.
Genomic regions of about 2kb either upstream of mce2A or
downstream of mce2B were obtained by PCR from M. bovis
total DNA by using the following pair of primers: 3 Δmce2
and5 Δmce2(Table 1).Theampliﬁedfragmentswerecloned
into the p2NIL plasmid [15] .T h eﬁ n a ld e l i v e r yv e c t o rw a s
generated by incorporation of the PacI cassette from pGOAL
17 into this last p2NIL recombinant vector. The vector
generated was pretreated with UV light (100mJ × cm−2)t o
induce depurination and promote recombination [22]. This
UV-treated plasmid was used to electroporate the collection
strain M. bovis NCTC 10772. The unmarked mutant was
obtained using a two-step strategy described previously [15],
and mutant clones were identiﬁed by colony PCR, using the
primers described in Table 1. The mutant strain resulting
from allelic exchange was designated MbΔmce2.
5.4. Cattle Infections. Holstein-Fresian calves (six months
old) were inoculated intratracheally as described previously
[32]wi t h1 0 6-107 colony forming units (CFU) of the mutant
MbΔmce2 (four animals) or its parental virulent strain
M. bovis NCTC 10772 (three animals). All experiments
conformed to local and national guidelines on the use of
experimental animals and category III infectious organisms.
All the animals used in this study were negative for IFN-
γ by ELISA assay (Bovigam) and tuberculin skin test at the
beginning of the experiments but positive by both assays at
the end of the experiments (data not shown). Blood samples
were taken both at the beginning of the experiment for
evaluation of preimmune status and at 15 and 90dpi.
Heparinized blood (10mL) from each animal was
used for PBMC isolation by gradient centrifugation over
Histopaque 1077 (Sigma Aldrich) following the manufac-
turer’s protocol. PBMCs were incubated at 37◦Ci nR P M I
complete medium supplemented with 10% of bovine fetal
serum (Internegocios) and 20μg/mL ﬁnal concentration of
PPDB (Biocor) on 12-well tissue culture plates for 16h for
RNA extraction and 48h for ﬂow cytometry determinations.
After three months of infection, the calves were eutha-
nized and then thin slices of lungs and lymph nodes of the
head and pulmonary region were analyzed looking for gran-
uloma formations. Only one of the animals inoculated with
the wild type NCTC 10772 strain developed macroscopic
lesionscompatiblewithtuberculosis(datanotshown).These
lesions were located in retropharyngeal lymph nodes. None
oftheanimalsinoculatedwiththemutantMbΔmce2showed
lesions.
5.5.FlowCytometry. Forﬂowcytometrydeterminations,2 ×
106 cells were incubated either with or without PPDB. To
evaluate the expression of CD4 (MCA 1653A647, IgG2a),
CD8 (MCA837PE, IgG2a), and CD25 (MCA2430F and
MCA2430PE) surface markers, cells were stained with
ﬂuorescent-conjugatedmonoclonalantibodies(AdDSerotec,
Oxford, UK).
Stained cells were analyzed in a FACScalibur cytometer
(BD, Franklin Lakes, NJ, USA) using Cell Quest software.
Analysis gates were set on lymphocytes according to forward
and side scatter. Expression of IL-2R was analyzed in CD4+
andCD8+populations.PercentagesofIL-2R-expressingcells
werecalculatedastheratioofCD4+orCD8+cellsexpressing
CD25 and total CD4+ or CD8+ cells.
5.6. Statistical Analysis. The data were organized in two sets,
one for CD4+ cells and the other for CD8+ cells. Each data
set recorded CDC25 expression in cells infected with two
diﬀerent M. bovis strains over time. Both sets were analyzed
independently as repeated measure designs over time. The
dependent variable was the expression of CDC25 in PPDB
stimulated cells, the bacterial strain was considered a ﬁxed
factor with two levels (MbΔmce2 and NCTC 10772), the
level of CDC25 in nonstimulated cells was included in the
models as a covariate, and time of sampling was treated as a
random factor. The analyses were performed using the nlme
library of R [33, 34].
5.7.CytokinemRNAAnalysis. TotalRNAwasextractedusing
a commercial kit (QIAGEN). The quality and quantity of
RNA and the synthesis of cDNA were assayed as described
previously [35].
The mRNAof cytokines (IL-2, IL-4, IL-10, IL-12p35,
TNF-α,a n dI F N - γ) was quantiﬁed by qPCR by using speciﬁc
primers (Table 1). qPCR results were analyzed using REST
software as described previously [10]. For each animal, the
preimmune condition was used as the calibrator, and pol IIJournal of Biomedicine and Biotechnology 7
Table 1: Primers used in this study.
Primers Sequences Tm (◦C) Application
3 Δmce2 F: GGATCCAAACGTTGGACCCAGACAAG
MbΔmce2 R: GCGGCCGCGGTGCTCATTGGTTGCTACC
5 Δmce2 F: AAGCTTTGGCGCTGCCGGTGACT
MbΔmce2 R: GGATCCCGCGGCTACACCGTGAGATT
Mut. mce2 del F: ACCCGAACTTCAATCTCACG
MbΔmce2 R: ACCTCACCTATCGCATGGTC
Pol II F:GGACCCGTGTGGACAAGAAT
76 qPCR R: ACAAGCCCCAGGTAATCATCC
GAPDH F: ATCTCTGCACCTTCTGCCGA
79 qPCR R: GCAGGAGGCATTGCTGACA
IL-2 F: CGTGCCCAAGGTTAACGCTA
76 qPCR R:CCATTGAATCCTTGATCTCTCTGG
IL-4 F: TGCCCCAAAGAACACAACTG
78 qPCR R: GCACGTGTGGCTCCTGTAGAT
IL-10 F: GGAAGAGGTGATGCCACAGG
84 qPCR R: AGGGCAGAAAGCGATGACAG
IL-12p35 F: TAGCCACGAATGAGAGTTGCC
78 qPCR R: TTTCCAGAAGCCAGACAATGC
TNF-α F: CCCCCAGAGGGAAGAGTCC
84 qPCR R:GGGCTACCGGCTTGTTACTTG
IFN-γ F: AGCTGATTCAAATTCCGGTGG
78 qPCR R:GATTTTGGCGACAGGTCATTC
and gadph were used as reference genes. Data were analyzed
using a two-tailed unpaired t-test.
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